Detalhe da pesquisa
1.
Carbon-to-nitrogen single-atom transmutation of azaarenes.
Nature
; 623(7985): 77-82, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914946
2.
Skeletal editing through direct nitrogen deletion of secondary amines.
Nature
; 593(7858): 223-227, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33981048
3.
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
N Engl J Med
; 388(19): 1739-1754, 2023 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163621
4.
Loss of Baz1b in mice causes perinatal lethality, growth failure, and variable multi-system outcomes.
Dev Biol
; 505: 42-57, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827362
5.
Detecting measurable residual disease beyond 10-4 by an IGHV leader-based NGS approach improves prognostic stratification in CLL.
Blood
; 141(5): 519-528, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084320
6.
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.
Blood
; 142(5): 446-459, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37172204
7.
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
Blood
; 142(13): 1131-1142, 2023 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37363833
8.
Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial.
Lancet Oncol
; 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38889735
9.
First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 25(6): 744-759, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38821083
10.
Evidence for Dearomatizing Spirocyclization and Dynamic Effects in the Quasi-stereospecific Nitrogen Deletion of Tetrahydroisoquinolines.
J Am Chem Soc
; 2024 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38899979
11.
Increased Heart Rate Fragmentation in Those with Williams-Beuren Syndrome Suggests Non-autonomic Mechanistic Contributors to Sudden Death Risk.
Am J Physiol Heart Circ Physiol
; 2024 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38904853
12.
Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(12): 1423-1433, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944541
13.
Direct Deaminative Functionalization.
J Am Chem Soc
; 145(1): 17-24, 2023 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36548788
14.
C-C Coupling through Nitrogen Deletion: Application to Library Synthesis.
Chemistry
; 29(4): e202204025, 2023 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599487
15.
C-C Coupling through Nitrogen Deletion: Application to Library Synthesis.
Chemistry
; 29(4): e202203470, 2023 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36445790
16.
Baz1b Dosage Influences Cardiovascular Function, Predisposing to Dilated Cardiomyopathy.
FASEB J
; 36 Suppl 12022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35723872
17.
Risk of cancer after ST-segment-elevation myocardial infarction.
Eur J Epidemiol
; 38(8): 853-858, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36947265
18.
Author Correction: Skeletal editing through direct nitrogen deletion of secondary amines.
Nature
; 608(7921): E11, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35817831
19.
Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial.
Lancet Oncol
; 23(6): 818-828, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35654052
20.
Unified Access to Pyrimidines and Quinazolines Enabled by N-N Cleaving Carbon Atom Insertion.
J Am Chem Soc
; 144(42): 19258-19264, 2022 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240487